Physiology - Division Z

Research output

Research output per year 1998 2010 2011 2012 2014 2015 2016 2017 2018 2019 2024

• 138 Article
• 15 Review article
• 9 Comment/debate
• 2 Chapter
• 2 More
  • 1 Letter
  • 1 Short survey

Research output per year

Research output per year

Search results

• 2024

  LILRB3 Supports Immunosuppressive Activity of Myeloid Cells and Tumor Development

  Huang, R., Liu, X., Kim, J., Deng, H., Deng, M., Gui, X., Chen, H., Wu, G., Xiong, W., Xie, J., Lewis, C., Homsi, J., Yang, X., Zhang, C., He, Y., Lou, Q., Smith, C., John, S., Zhang, N., An, Z., & 1 othersZhang, C. C., Mar 1 2024, In: Cancer Immunology Research. 12, 3, p. 350-362 13 p.

  Research output: Contribution to journal › Article › peer-review

  • Myeloid Cells 100%
  • Immunosuppressive Agents 81%
  • Leukocytes 77%
  • Neoplasms 31%
  • Galectin 4 19%
  2 Scopus citations
• 2023

  Antibody therapies for the treatment of acute myeloid leukemia: exploring current and emerging therapeutic targets

  Morse, J. W., Rios, M., Ye, J., Rios, A., Zhang, C. C., Daver, N. G., DiNardo, C. D., Zhang, N. & An, Z., 2023, In: Expert Opinion on Investigational Drugs. 32, 2, p. 107-125 19 p.

  Research output: Contribution to journal › Review article › peer-review

  • Acute Myeloid Leukemia 100%
  • Antibodies 58%
  • Bispecific Antibodies 29%
  • Therapeutics 17%
  • Gemtuzumab 17%
  1 Scopus citations
• 2022

  An old player, the right niche

  Zhang, C. C., Apr 1 2022, In: Blood Science. 4, 2, p. 99 1 p.

  Research output: Contribution to journal › Comment/debate › peer-review

  Open Access

• A perspective on LILRBs and LAIR1 as immune checkpoint targets for cancer treatment

  Zhang, C. C., Dec 10 2022, In: Biochemical and Biophysical Research Communications. 633, p. 64-67 4 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Myeloid Cells 100%
  • leukocyte-associated immunoglobulin-like receptor 1 96%
  • Immunosuppressive Agents 81%
  • Leukocytes 77%
  • Tumor Microenvironment 50%
  7 Scopus citations

• Blocking LAIR1 signaling in immune cells inhibits tumor development

  Xie, J., Gui, X., Deng, M., Chen, H., Chen, Y., Liu, X., Ku, Z., Tan, L., Huang, R., He, Y., Zhang, B., Lewis, C., Chen, K., Xu, L., Xu, J., Huang, T., Liao, X. C., Zhang, N., An, Z. & Zhang, C. C., Sep 21 2022, In: Frontiers in immunology. 13, 996026.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • leukocyte-associated immunoglobulin-like receptor 1 100%
  • Neoplasms 16%
  • human LILRB1 protein 11%
  • Macrophages 10%
  • T-Lymphocytes 9%
  7 Scopus citations

• LILRB2-mediated TREM2 signaling inhibition suppresses microglia functions

  Zhao, P., Xu, Y., Jiang, L. L., Fan, X., Ku, Z., Li, L., Liu, X., Deng, M., Arase, H., Zhu, J. J., Huang, T. Y., Zhao, Y., Zhang, C., Xu, H., Tong, Q., Zhang, N. & An, Z., Dec 2022, In: Molecular neurodegeneration. 17, 1, 44.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Myeloid Cells 100%
  • Microglia 99%
  • Immunoglobulins 86%
  • Psychological Inhibition 79%
  • Leukocytes 77%
  11 Scopus citations

• YAP inhibits ERα and ER⁺ breast cancer growth by disrupting a TEAD-ERα signaling axis

  Li, X., Zhuo, S., Zhuang, T., Cho, Y. S., Wu, G., Liu, Y., Mu, K., Zhang, K., Su, P., Yang, Y., Zhang, C. C., Zhu, J. & Jiang, J., Dec 2022, In: Nature communications. 13, 1, 3075.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • disrupting 100%
  • Enhancer 84%
  • breast 74%
  • hormones 66%
  • cancer 66%
  25 Scopus citations
• 2021

  Corrigendum to “The association of leukocyte immunoglobulin-like receptor subfamily B-4 expression in acute myeloid leukemia and central nervous system involvement” [Leukemia Res. 100 (2021) 106480] (Leukemia Research (2021) 100, (S0145212620301855), (10.1016/j.leukres.2020.106480))

  Bergstrom, C. P., Dahiya, S., Chen, W., Zhang, C. C., Zhu, H., Yan, J., Madanat, Y., Patel, P., Vusirkala, M., Ramakrishnan, P., Rizvi, S., Chung, S., Awan, F., Anderson, L. D., Collins, R. & Kansagra, A., May 2021, In: Leukemia Research. 104, 106563.

  Research output: Contribution to journal › Comment/debate › peer-review

  • Conflict of Interest 100%
  • Acute Myeloid Leukemia 74%
  • Immunoglobulins 69%
  • Leukemia 64%
  • Leukocytes 62%

• Leukocyte immunoglobulin-like receptor B1 and B4 (LILRB1 and LILRB4): Highly sensitive and specific markers of acute myeloid leukemia with monocytic differentiation

  Churchill, H. R. O., Fuda, F. S., Xu, J., Deng, M., Zhang, C. C., An, Z., Zhang, N., Chen, P., Bergstrom, C., Kansagra, A., Collins, R., John, S., Koduru, P. & Chen, W., Jul 2021, In: Cytometry Part B - Clinical Cytometry. 100, 4, p. 476-487 12 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Leukocyte Immunoglobulin-like Receptor B1 100%
  • Acute Myeloid Leukemia 50%
  • Monocytes 38%
  • Monocyte-Macrophage Precursor Cells 18%
  • N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide 12%
  9 Scopus citations

• Leukocyte immunoglobulin-like receptor subfamily B: therapeutic targets in cancer

  Deng, M., Chen, H., Liu, X., Huang, R., He, Y., Yoo, B., Xie, J., John, S., Zhang, N., An, Z. & Cheng Zhang, C., Jan 1 2021, In: Antibody Therapeutics. 4, 1, p. 16-33 18 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Immunoglobulins 100%
  • Leukocytes 89%
  • Neoplasms 36%
  • Immune Evasion 23%
  • Phosphoric Monoester Hydrolases 19%
  23 Scopus citations

• Lilrb1: A novel diagnostic b-cell marker to distinguish neoplastic b lymphoblasts from hematogones

  Saumell Tutusaus, S., Pirruccello, E., Fuda, F., Churchill, H., Chen, D., Zhang, C. C. & Chen, W., Dec 1 2021, In: American journal of clinical pathology. 156, 6, p. 941-949 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Immunoglobulins 100%
  • Leukocytes 89%
  • B-Lymphocytes 69%
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma 22%
  • Immunotherapy 19%
  1 Scopus citations

• LILRB3 supports acute myeloid leukemia development and regulates T-cell antitumor immune responses through the TRAF2–cFLIP–NF-κB signaling axis

  Wu, G., Xu, Y., Schultz, R. D., Chen, H., Xie, J., Deng, M., Liu, X., Gui, X., John, S., Lu, Z., Arase, H., Zhang, N., An, Z. & Zhang, C. C., Nov 2021, In: Nature Cancer. 2, 11, p. 1170-1184 15 p.

  Research output: Contribution to journal › Article › peer-review

  • Acute Myeloid Leukemia 100%
  • TNF Receptor-Associated Factor 2 79%
  • T-Lymphocytes 64%
  • Myeloid Cells 26%
  • Immunoglobulins 23%
  24 Scopus citations

• Membrane protein CAR promotes hematopoietic regeneration upon stress

  Wu, G. & Zhang, C. C., Aug 2021, In: Haematologica. 106, 8, p. 2180-2190 11 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Hematopoietic Stem Cells 100%
  • Regeneration 84%
  • Membrane Proteins 83%
  • adenovirus receptor 20%
  • Cell Cycle 19%
  4 Scopus citations

• Silencing of LINE-1 retrotransposons is a selective dependency of myeloid leukemia

  Gu, Z., Liu, Y., Zhang, Y., Cao, H., Lyu, J., Wang, X., Wylie, A., Newkirk, S. J., Jones, A. E., Lee, M., Botten, G. A., Deng, M., Dickerson, K. E., Zhang, C. C., An, W., Abrams, J. M. & Xu, J., May 2021, In: Nature genetics. 53, 5, p. 672-682 11 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Retroelements 100%
  • Myeloid Leukemia 93%
  • Acute Myeloid Leukemia 72%
  • Long Interspersed Nucleotide Elements 29%
  • Neoplasms 24%
  35 Scopus citations

• The association of leukocyte immunoglobulin-like receptor subfamily B-4 expression in acute myeloid leukemia and central nervous system involvement

  Bergstrom, C. P., Dahiya, S., Chen, W., Zhang, C. C., Zhu, H., Yan, J., Madanat, Y., Patel, P., Vusirkala, M., Ramakrishnan, P., Rizvi, S., Chung, S., Awan, F., Anderson, L. D., Collins, R. & Kansagra, A., Jan 2021, In: Leukemia Research. 100, 106480.

  Research output: Contribution to journal › Article › peer-review

  • Acute Myeloid Leukemia 100%
  • Immunoglobulins 92%
  • Leukocytes 83%
  • Central Nervous System 77%
  • Investigational Therapies 11%
  5 Scopus citations
• 2020

  Antagonistic anti-LILRB1 monoclonal antibody regulates antitumor functions of natural killer cells

  Chen, H., Chen, Y., Deng, M., John, S., Gui, X., Kansagra, A., Chen, W., Kim, J., Lewis, C., Wu, G., Xie, J., Zhang, L., Huang, R., Liu, X., Arase, H., Huang, Y., Yu, H., Luo, W., Xia, N., Zhang, N., & 2 othersAn, Z. & Zhang, C. C., Aug 7 2020, In: Journal for ImmunoTherapy of Cancer. 8, 2, e000515.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Leukocyte Immunoglobulin-like Receptor B1 100%
  • Natural Killer Cells 49%
  • Monoclonal Antibodies 38%
  • Multiple Myeloma 16%
  • Tissue Donors 9%
  27 Scopus citations

• Correction to: LILRB4 ITIMs mediate the T cell suppression and infiltration of acute myeloid leukemia cells (Cellular & Molecular Immunology, (2020), 17, 3, (272-282), 10.1038/s41423-019-0321-2)

  Li, Z., Deng, M., Huang, F., Jin, C., Sun, S., Chen, H., Liu, X., He, L., Sadek, A. H. & Zhang, C. C., Mar 1 2020, In: Cellular and Molecular Immunology. 17, 3, p. 302-304 3 p.

  Research output: Contribution to journal › Comment/debate › peer-review

  Open Access

  • Allergy and Immunology 100%
  • Myeloid Cells 95%
  • Acute Myeloid Leukemia 89%
  • T-Lymphocytes 57%
  2 Scopus citations

• LILRB4 ITIMs mediate the T cell suppression and infiltration of acute myeloid leukemia cells

  Li, Z., Deng, M., Huang, F., Jin, C., Sun, S., Chen, H., Liu, X., He, L., Sadek, A. H. & Zhang, C. C., Mar 1 2020, In: Cellular and Molecular Immunology. 17, 3, p. 272-282 11 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Myeloid Cells 100%
  • Acute Myeloid Leukemia 93%
  • Tyrosine 90%
  • Leukocyte Immunoglobulin-like Receptor B1 74%
  • T-Lymphocytes 60%
  32 Scopus citations

• LILRB4-targeting antibody–drug conjugates for the treatment of acute myeloid leukemia

  Anami, Y., Deng, M., Gui, X., Yamaguchi, A., Yamazaki, C. M., Zhang, N., Zhang, C. C., An, Z. & Tsuchikama, K., Nov 1 2020, In: Molecular Cancer Therapeutics. 19, 11, p. 2330-2339 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Acute Myeloid Leukemia 100%
  • Immunoglobulins 92%
  • Leukocytes 83%
  • Gemtuzumab 42%
  • Myeloid Cells 40%
  27 Scopus citations

• Signal transduction from small particles: Sulfur nanodots featuring mercury sensing, cell entry mechanism and in vitro tracking performance

  Qiao, G., Liu, L., Hao, X., Zheng, J., Liu, W., Gao, J., Zhang, C. C. & Wang, Q., Feb 15 2020, In: Chemical Engineering Journal. 382, 122907.

  Research output: Contribution to journal › Article › peer-review

  • Nanodots 100%
  • Signal transduction 81%
  • Signal Transduction 59%
  • Sulfur 52%
  • mercury 44%
  113 Scopus citations
• 2019

  Aggregation-induced-emission (AIE) directed assembly of a novel responsive nanoprobe for dual targets sensing

  Zhou, Z., Li, X., Zhang, Y., Zhang, C. C., Tang, Y., Gao, J., Ma, L. & Wang, Q., Jun 2019, In: Materials Science and Engineering C. 99, p. 1092-1098 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Nanoprobes 100%
  • Sodium 56%
  • Sulfonate 51%
  • Agglomeration 48%
  • Thermoplastic elastomers 31%
  13 Scopus citations

• Biocompatible Nanoplatform Based on Mussel Adhesive Chemistry: Effective Assembly, Dual Mode Sensing, and Cellular Imaging Performance

  Wu, N., Yu, A., Zhang, L., Liu, W., Gao, J., Zhang, C. & Zheng, Y., Sep 1 2019, In: Advanced Materials Interfaces. 6, 17, 1900732.

  Research output: Contribution to journal › Article › peer-review

  • Silver 100%
  • Nanoparticles 90%
  • Ions 84%
  • Condensation reactions 77%
  • Sodium Borohydride 73%
  26 Scopus citations

• Cas9-induced immune response: A potential caution for human genome editing

  Zhang, C. C., Dec 17 2019, In: Biochemical and Biophysical Research Communications. 520, 4, p. 706-707 2 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  2 Scopus citations

• Disrupting LILRB4/APOE Interaction by an Efficacious Humanized Antibody Reverses T-cell Suppression and Blocks AML Development

  Gui, X., Deng, M., Song, H., Chen, Y., Xie, J., Li, Z., He, L., Huang, F., Xu, Y., Anami, Y., Yu, H., Yu, C., Li, L., Yuan, Z., Xu, X., Wang, Q., Chai, Y., Huang, T., Shi, Y., Tsuchikama, K., & 6 othersCharlene Liao, X., Xia, N., Gao, G. F., Zhang, N., Zhang, C. C. & An, Z., 2019, In: Cancer Immunology Research. 7, 8, p. 1244-1257 14 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Antibodies, Monoclonal, Humanized 100%
  • Acute Myeloid Leukemia 73%
  • Immunoglobulins 68%
  • Leukocytes 61%
  • T-Lymphocytes 47%
  47 Scopus citations

• Installation of a cancer promoting WNT/SIX1 signaling axis by the oncofusion protein MLL-AF9

  Zhang, L. S., Kang, X., Lu, J., Zhang, Y., Wu, X., Wu, G., Zheng, J., Tuladhar, R., Shi, H., Wang, Q., Morlock, L., Yao, H., Huang, J-S., Maire, P., Kim, J., Williams, N. S., Xu, J., Chen, C., Zhang, C. & Lum, L., Jan 2019, In: EBioMedicine. 39, p. 145-158 14 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Catenins 100%
  • Acute Myeloid Leukemia 56%
  • Effector 43%
  • Protein 32%
  • Proteins 29%
  13 Scopus citations

• In vitro monitoring of glutathione via a switched-on effect based on a lanthanide incorporated carbon nanostructure with biocompatibility

  Wen, Q., Zeng, Z., Liu, W., Gao, J., Zhang, H. M., Zhang, C. C. & Zheng, Y., Nov 2019, In: Synthetic Metals. 257, 116183.

  Research output: Contribution to journal › Article › peer-review

  • Glutathione 100%
  • Europium 96%
  • glutathione 83%
  • Rare earth elements 75%
  • Biocompatibility 66%
  3 Scopus citations

• Metabolic Imaging Reveals a Unique Preference of Symmetric Cell Division and Homing of Leukemia-Initiating Cells in an Endosteal Niche

  Hao, X., Gu, H., Chen, C., Huang, D., Zhao, Y., Xie, L., Zou, Y., Shu, H. S., Zhang, Y., He, X., Lai, X., Zhang, X., Zhou, B. O., Zhang, C. C., Chen, G. Q., Yu, Z., Yang, Y. & Zheng, J., Apr 2 2019, In: Cell Metabolism. 29, 4, p. 950-965.e6

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Cell Division 100%
  • Leukemia 86%
  • Glycolysis 18%
  • Acute Myeloid Leukemia 8%
  • In Vitro Techniques 7%
  43 Scopus citations

• Next-generation antibody therapeutics: Discovery, development and beyond: Highlights of the third annual conference of the chinese antibody society

  Zhang, H., Deng, M., Pei, F., Wang, S. & Ho, M., 2019, In: Antibody Therapeutics. 2, 4, p. 88-96 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Congresses 100%
  • Bispecific Antibodies 71%
  • Antibodies 56%
  • Single-Domain Antibodies 49%
  • Immunotoxins 45%
  1 Scopus citations

• Phagocytosis checkpoints as new targets for cancer immunotherapy

  Feng, M., Jiang, W., Kim, B. Y. S., Zhang, C. C., Fu, Y. X. & Weissman, I. L., Oct 1 2019, In: Nature Reviews Cancer. 19, 10, p. 568-586 19 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Phagocytosis 100%
  • Immunotherapy 89%
  • Adaptive Immunity 34%
  • Neoplasms 32%
  • Tumor Escape 22%
  514 Scopus citations

• The approval of sintilimab for classical hodgkin's lymphoma: Views and perspectives of anti-pd-1/pd-l1 antibodies in china

  Deng, M., 2019, In: Antibody Therapeutics. 2, 2, p. 54-55 2 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access
  4 Scopus citations
• 2018

  Another way to not get eaten news-and-views

  Zhang, C. & Fu, Y-X., Jan 1 2018, In: Nature Immunology. 19, 1, p. 6-7 2 p.

  Research output: Contribution to journal › Short survey › peer-review
  8 Scopus citations

• A Novel Anti-LILRB4 CAR-T Cell for the Treatment of Monocytic AML

  John, S., Chen, H., Deng Ph.D., M., Gui, X., Wu, G., Chen, W., Li, Z., Zhang, N., An, Z. & Zhang, C., Oct 3 2018, In: Molecular Therapy. 26, 10, p. 2487-2495 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Chimeric Antigen Receptors 100%
  • Acute Myeloid Leukemia 70%
  • Immunoglobulins 65%
  • Antigen 62%
  • Leukocytes 58%
  72 Scopus citations

• CAMKs support development of acute myeloid leukemia

  Kang, X., Cui, C., Wang, C., Wu, G., Chen, H., Lu, Z., Chen, X., Wang, L., Huang, J., Geng, H., Zhao, M., Chen, Z., Müschen, M., Wang, H. Y. & Zhang, C., Feb 27 2018, In: Journal of Hematology and Oncology. 11, 1, 30.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Calcium-Calmodulin-Dependent Protein Kinases 100%
  • Acute Myeloid Leukemia 76%
  • Myeloid Cells 27%
  • Angiopoietin-like Proteins 14%
  • Leukemia 14%
  20 Scopus citations

• Correction: SHP-1 regulates hematopoietic stem cell quiescence by coordinating TGF-β signaling (Journal of Experimental Medicine (2018) 215:5 DOI: 10.1084/jem.20171477)

  Jiang, L., Han, X., Wang, J., Wang, C., Sun, X., Xie, J., Wu, G., Phan, H., Liu, Z., Yeh, E. T. H., Zhang, C. C., Zhao, M. & Kang, X., Sep 1 2018, In: Journal of Experimental Medicine. 215, 8, p. 2227 1 p.

  Research output: Contribution to journal › Comment/debate › peer-review

  Open Access

  • Biomedical Research 100%
  • Hematopoietic Stem Cells 98%
  • Emotions 78%
  4 Scopus citations

• Frontiers and Opportunities: Highlights of the 2^nd Annual Conference of the Chinese Antibody Society

  Zhang, H., Deng, M., Lin, P., Liu, J., Liu, C., Strohl, W. R., Wang, S. & Ho, M., Nov 5 2018, In: Antibody Therapeutics. 1, 2, p. 65-74 10 p., tby009.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Antibodies 100%
  • Congresses 59%
  • China 48%
  • T-Cell Antigen Receptor 30%
  • Programmed Cell Death 1 Receptor 21%
  20 Scopus citations

• Glatiramer acetate enhances myeloid-derived suppressor cell function via recognition of paired Ig-like receptor B

  Van Der Touw, W., Kang, K., Luan, Y., Ma, G., Mai, S., Qin, L., Bian, G., Zhang, R., Mungamuri, S. K., Hu, H. M., Zhang, C., Aaronson, S. A., Feldmann, M., Yang, W. C., Chen, S. H. & Pan, P. Y., Sep 15 2018, In: Journal of Immunology. 201, 6, p. 1727-1734 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Glatiramer Acetate 100%
  • Myeloid-Derived Suppressor Cells 91%
  • Cytokines 42%
  • Relapsing-Remitting Multiple Sclerosis 28%
  • Granulocyte-Macrophage Colony-Stimulating Factor 24%
  12 Scopus citations

• In vitro and in vivo studies of a chlorin-based carbon nanocarrier with photodynamic therapy features

  Zhou, Z., Zheng, Y., Zhang, C. C., Gao, J., Tang, Y. & Wang, Q., 2018, In: Photochemical and Photobiological Sciences. 17, 10, p. 1329-1336 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Carbon Nanohorn 100%
  • Nanocarrier 74%
  • therapy 65%
  • carbon 45%
  • Carbon Nanostructure 41%
  3 Scopus citations

• JAM3 maintains leukemia-initiating cell self-renewal through LRP5/AKT/β-catenin/CCND1 signaling

  Zhang, Y., Xia, F., Liu, X., Yu, Z., Xie, L., Liu, L., Chen, C., Jiang, H., Hao, X., He, X., Zhang, F., Gu, H., Zhu, J., Bai, H., Zhang, C., Chen, G. Q. & Zheng, J., May 1 2018, In: Journal of Clinical Investigation. 128, 5, p. 1737-1751 15 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Junctional Adhesion Molecule C 100%
  • Catenins 65%
  • Cell Self Renewal 65%
  • Leukemia 42%
  • Intercellular Junctions 5%
  38 Scopus citations

• LILRB4 signalling in leukaemia cells mediates T cell suppression and tumour infiltration

  Deng, M., Gui, X., Kim, J., Xie, L., Chen, W., Li, Z., He, L., Chen, Y., Chen, H., Luo, W., Lu, Z., Xie, J., Churchill, H., Xu, Y., Zhou, Z., Wu, G., Yu, C., John, S., Hirayasu, K., Nguyen, N., & 26 othersLiu, X., Huang, F., Li, L., Deng, H., Tang, H., Sadek, A. H., Zhang, L., Huang, T., Zou, Y., Chen, B., Zhu, H., Arase, H., Xia, N., Jiang, Y., Collins, R., You, M. J., Homsi, J., Unni, N., Lewis, C., Chen, G. Q., Fu, Y. X., Liao, X. C., An, Z., Zheng, J., Zhang, N. & Zhang, C., Oct 25 2018, In: Nature. 562, 7728, p. 605-609 5 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Leukemia 100%
  • T-Lymphocytes 75%
  • Acute Myeloid Leukemia 58%
  • Neoplasms 39%
  • Immunoreceptor Tyrosine-Based Inhibition Motif 36%
  163 Scopus citations

• Luminescence modulation of two individual fluorophores over a wide pH range and intracellular studies

  Zhou, Z., Zhang, C., Zheng, Y. & Wang, Q., Mar 2018, In: Dyes and Pigments. 150, p. 151-157 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Europium 100%
  • Fluorophores 93%
  • Luminescence 82%
  • Modulation 43%
  • Luminiscence Type 39%
  29 Scopus citations

• Modulation of assembly and disassembly of a new tetraphenylethene based nanosensor for highly selective detection of hyaluronidase

  Li, X., Zhou, Z., Tang, Y., Zhang, C., Zheng, Y., Gao, J. & Wang, Q., Dec 10 2018, In: Sensors and Actuators, B: Chemical. 276, p. 95-100 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Hyaluronic acid 100%
  • Nanosensors 92%
  • Hyaluronic Acid 67%
  • Fluorescence quenching 57%
  • Nanoprobes 52%
  44 Scopus citations

• Multi-modal tracking dopamine using a hybrid inorganic-organic silver nanoparticle and its cellular imaging performance

  Zhou, Z., Wang, Z., Tang, Y., Gao, J., Zhang, C. & Wang, Q., Dec 2018, In: Journal of Luminescence. 204, p. 394-400 7 p.

  Research output: Contribution to journal › Article › peer-review

  • dopamine 100%
  • Silver 69%
  • Dopamine 61%
  • Terbium 58%
  • Silver Nanoparticle 58%
  6 Scopus citations

• Mussel chemistry assembly of a novel biosensing nanoplatform based on polydopamine fluorescent dot and its photophysical features

  Chen, M., Wen, Q., Gu, F., Gao, J., Zhang, C. & Wang, Q., Jun 15 2018, In: Chemical Engineering Journal. 342, p. 331-338 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Wavelength 100%
  • wavelength 85%
  • Nanoparticles 74%
  • nanoparticle 70%
  • Glutathione 69%
  44 Scopus citations

• NK cell-mediated anti-leukemia cytotoxicity is enhanced using a NKG2D ligand MICA and anti-CD20 scfv chimeric protein

  Zou, Y., Luo, W., Guo, J., Luo, Q., Deng Ph.D., M., Lu, Z., Fang, Y. & Zhang, C., Oct 2018, In: European Journal of Immunology. 48, 10, p. 1750-1763 14 p.

  Research output: Contribution to journal › Article › peer-review

  • Natural Killer Cells 100%
  • Leukemia 88%
  • Ligands 76%
  • Proteins 39%
  • Recombinant Proteins 30%
  7 Scopus citations

• Oxidative deoximation reaction induced recognition of hypochlorite based on a new fluorescent lanthanide-organic framework

  Zhou, Z., Li, X., Tang, Y., Zhang, C. C., Fu, H., Wu, N., Ma, L., Gao, J. & Wang, Q., Nov 1 2018, In: Chemical Engineering Journal. 351, p. 364-370 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Oximes 100%
  • Europium 95%
  • Deoximation 89%
  • Photoluminescence 86%
  • europium 74%
  65 Scopus citations

• PPM1K Regulates Hematopoiesis and Leukemogenesis through CDC20-Mediated Ubiquitination of MEIS1 and p21

  Liu, X., Zhang, F., Zhang, Y., Li, X., Chen, C., Zhou, M., Yu, Z., Liu, Y., Zhao, Y., Hao, X., Tang, Y., Zhu, L., Liu, L., Xie, L., Gu, H., Shao, H., Xia, F., Yin, C., Tao, M., Xie, J., & 5 othersZhang, C., Yang, Y., Sun, H., Chen, G. Q. & Zheng, J., May 1 2018, In: Cell Reports. 23, 5, p. 1461-1475 15 p.

  Research output: Contribution to journal › Article › peer-review

  • Branched-Chain Amino Acid 100%
  • Branched Chain Amino Acids 90%
  • Hematopoiesis 75%
  • Ubiquitination 75%
  • Hematopoietic Stem Cells 68%
  46 Scopus citations

• Ratiometric Fluorescence Platform Based on Modified Silicon Quantum Dots and Its Logic Gate Performance

  Li, X., Zhou, Z., Zhang, C., Zheng, Y., Gao, J. & Wang, Q., Aug 6 2018, In: Inorganic Chemistry. 57, 15, p. 8866-8873 8 p.

  Research output: Contribution to journal › Article › peer-review

  • logic 100%
  • Quantum Dot 91%
  • platforms 86%
  • quantum dots 79%
  • fluorescence 76%
  56 Scopus citations

• SHP-1 regulates hematopoietic stem cell quiescence by coordinating TGF-ß signaling

  Jiang, L., Han, X., Wang, J., Wang, C., Sun, X., Xie, J., Wu, G., Phan, H., Liu, Z., Zhang, C., Zhao, M. & Kang, X., May 1 2018, In: Journal of Experimental Medicine. 215, 5, p. 1337-1347 11 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Hematopoietic Stem Cells 100%
  • Immunoreceptor Tyrosine-Based Inhibition Motif 36%
  • Maintenance 28%
  • Megakaryocytes 24%
  • Cell Cycle 15%
  37 Scopus citations
• 2017

  A STING-activating nanovaccine for cancer immunotherapy

  Luo, M., Wang, H., Wang, Z., Cai, H., Lu, Z., Li, Y., Du, M., Huang, G., Wang, C., Chen, X., Porembka, M. R., Lea, J., Frankel, A. E., Fu, Y. X., Chen, Z. J. & Gao, J., Jul 1 2017, In: Nature Nanotechnology. 12, 7, p. 648-654 7 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Interferons 100%
  • interferon 97%
  • genes 65%
  • Tumors 57%
  • tumors 53%
  621 Scopus citations

• B7-H4 enhances the differentiation of murine leukemia-initiating cells via the PTEN/AKT/RCOR2/RUNX1 pathways

  Xia, F., Zhang, Y., Xie, L., Jiang, H., Zeng, H., Chen, C., Liu, L., He, X., Hao, X., Fang, X., Liu, X., Zhang, F., Gu, H., Wan, J., Cheng, Y., Zhang, C., Chen, G. Q., Lu, Y., Yu, Z. & Zheng, J., Oct 1 2017, In: Leukemia. 31, 10, p. 2260-2264 5 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  9 Scopus citations